1-20 of 34 results for subject:"Pharmaceutical Services Negotiating Committee"
Librarians' tools
- Search time
- 0.298 seconds
- Solr query time
- 0.003 seconds
- Search query
- subject:"Pharmaceutical Services Negotiating Committee"
- We searched for
- subject_t:"Pharmaceutical Services Negotiating Committee" OR subject_t:PSNC OR subject_ses:61591
Type
House
Session
Year
Department
Member
More
Primary member
Answering member
Legislative stage
Legislation
Subject
More
Publisher
To ask the Secretary of State for Health and Social Care, what recent assessment he has made of the implications for his policies of the findings of the Pharmaceutical Services Negotiating Committee, published in April 2022, on pressures on the operation of community pharmacies.
To ask the Secretary of State for Health and Social Care, what recent assessment he has made of the implications for his policies of the findings of the Pharmaceutical Services Negotiating Committee, published in April 2022, on pressures on the operation of community pharmacies.
No assessment has been made. The Community Pharmacy Contractual Framework 2019-24 sets out the ambition for community pharmacy to be further integrated into the National Health Service, making better use of the clinical skills of pharmacists, provide more clinical services and provide treatment for minor illnesses. Negotiations with the Pharmaceutical Service Negotiating Committee on what community pharmacy will deliver in 2022/23 are ongoing and includes discussion on pressures on community pharmacies.
My Lords, I welcome and support this statutory instrument. In fact, it is an excellent example of the contribution and innovation that community pharmacies make. Disappointingly, this has not always been recognised by the NHS, nor financially supported by the Government. As the Pharmaceutical Services Negotiating Committee has pointed out,...
My Lords, I welcome and support this statutory instrument. In fact, it is an excellent example of the contribution and innovation that community pharmacies make. Disappointingly, this has not always been recognised by the NHS, nor financially supported by the Government. As the Pharmaceutical Services Negotiating Committee has pointed out,...
Lords motion to regret. Motion debated and withdrawn.
Lords motion to regret. Motion debated and withdrawn.
My Lords, I thank the noble Lord, Lord Hunt of Kings Heath, for introducing this debate. It is a most timely and important one. As I sat down to prepare my speech for today, I thought back to a year ago, and two places. One was the relatively affluent suburb...
My Lords, I thank the noble Lord, Lord Hunt of Kings Heath, for introducing this debate. It is a most timely and important one. As I sat down to prepare my speech for today, I thought back to a year ago, and two places. One was the relatively affluent suburb...
My Lords, I start by declaring my interest with the Dispensing Doctors’ Association, as in the register of Members’ interests.
I welcome the regulations before us this afternoon; the instrument makes a permanent change to broaden the existing arrangements for the supply of prescription items for pandemic disease or in other...
My Lords, I start by declaring my interest with the Dispensing Doctors’ Association, as in the register of Members’ interests.
I welcome the regulations before us this afternoon; the instrument makes a permanent change to broaden the existing arrangements for the supply of prescription items for pandemic disease or in other...
My Lords, as others have said, community pharmacies make a huge contribution to life in the UK. I support this narrow statutory instrument but I deplore the position in which so many pharmacies have been left.
Let us look at what community pharmacies do and what they could do. They already...
My Lords, as others have said, community pharmacies make a huge contribution to life in the UK. I support this narrow statutory instrument but I deplore the position in which so many pharmacies have been left.
Let us look at what community pharmacies do and what they could do. They already...
My Lords, I thank the noble Lord, Lord Hunt, for tabling this regret Motion. I echo his opening remarks about supporting the principles set out in the regulations, but proper resources are needed.
We on these Benches thank the All-Party Pharmacy Group, the Company Chemists’ Association, the Pharmaceutical Services Negotiating Committee...
My Lords, I thank the noble Lord, Lord Hunt, for tabling this regret Motion. I echo his opening remarks about supporting the principles set out in the regulations, but proper resources are needed.
We on these Benches thank the All-Party Pharmacy Group, the Company Chemists’ Association, the Pharmaceutical Services Negotiating Committee...
Like my noble friend Lord Hunt, I welcome the purpose of the 2021 regulations, as community pharmacies are contracted and commissioned in England under the national community pharmacy contractual framework, which
sets out the services that need to be provided, how quality is assured and other expectations, such as safety.
As...
Like my noble friend Lord Hunt, I welcome the purpose of the 2021 regulations, as community pharmacies are contracted and commissioned in England under the national community pharmacy contractual framework, which
sets out the services that need to be provided, how quality is assured and other expectations, such as safety.
As...
My Lords, I thank the noble Lord, Lord Hunt of Kings Heath, for tabling the Motion on this topic. I also take this opportunity to express our profound thanks to community pharmacies. The noble Lord, Lord Hunt, put it extremely well. They are an absolutely key part of our NHS...
My Lords, I thank the noble Lord, Lord Hunt of Kings Heath, for tabling the Motion on this topic. I also take this opportunity to express our profound thanks to community pharmacies. The noble Lord, Lord Hunt, put it extremely well. They are an absolutely key part of our NHS...
My Lords, this has been a very good debate. I am grateful to all noble Lords, and the Minister, for their interesting contributions. Although this was essentially about the funding of community pharmacy, the huge contribution that it makes—and can make in the future—became very apparent in this debate. I...
My Lords, this has been a very good debate. I am grateful to all noble Lords, and the Minister, for their interesting contributions. Although this was essentially about the funding of community pharmacy, the huge contribution that it makes—and can make in the future—became very apparent in this debate. I...
To ask the Chancellor of the Exchequer, what recent representations he has received from the Pharmaceutical Services Negotiating Committee on advance payments to pharmacies during the covid-19 outbreak.
To ask the Chancellor of the Exchequer, what recent representations he has received from the Pharmaceutical Services Negotiating Committee on advance payments to pharmacies during the covid-19 outbreak.
The Treasury received representations from the Pharmaceutical Services Negotiating Committee concerning advance payments to pharmacies during the Covid-19 pandemic in March 2021.
The Government has put in place a comprehensive package of support for community pharmacy during the pandemic, including providing extra funding for Bank Holiday openings, advance cash payments, a new medicines delivery service for shielded patients and a contribution to social distancing for every pharmacy.
The Government has also put forward proposals for additional funding to meet extra costs incurred by pharmacies during the pandemic, and discussions between the Department of Health and Social Care and the Pharmaceutical Services Negotiating Committee (PSNC) are ongoing.
To ask the Secretary of State for Health, (a) on how many occasions during the most recent negotiation period Ministers and officials of his Department met with representatives from the Pharmaceutical Services Negotiating Committee and (b) when he plans to announce a funding package for community pharmacy for 2016-17.
To ask the Secretary of State for Health, (a) on how many occasions during the most recent negotiation period Ministers and officials of his Department met with representatives from the Pharmaceutical Services Negotiating Committee and (b) when he plans to announce a funding package for community pharmacy for 2016-17.
Since 9 September 2016, when a revised package of measures was put to the Pharmaceutical Services Negotiation Committee (PSNC), the Department, supported by NHS England, has met the PSNC on four occasions. I have met PSNC three times since 30 August 2016, including on 6 October 2016.
Ministers are still in a process of considering a proposed package for the community pharmacy sector and are expecting to make an announcement shortly.
To ask the Secretary of State for Health, what recent discussions he has had with the Pharmaceutical Services Negotiating Committee.
To ask the Secretary of State for Health, what recent discussions he has had with the Pharmaceutical Services Negotiating Committee.
Community pharmacy is a vital part of the National Health Service and can play an even greater role. In the Spending Review, the Government re-affirmed the need for the NHS to deliver £22 billion in efficiency savings by 2020/21 as set out in the NHS’s own plan, the Five Year Forward View. Community pharmacy is a core part of NHS primary care and has an important contribution to make as the NHS rises to these challenges. The Government believes efficiencies can be made without compromising the quality of services or public access to them. Our aim is to ensure that those community pharmacies upon which people depend continue to thrive and so we are consulting on the introduction of a Pharmacy Access Scheme, which will provide more NHS funds to certain pharmacies compared to others, considering factors such as location and the health needs of the local population.
The Government’s vision is for a more efficient, modern system that will free up pharmacists to spend more time delivering clinical and public health services to the benefit of patients and the public.
We have been in detailed discussions with the Pharmaceutical Services Negotiating Committee (PSNC) since December 2015 regarding the Government’s proposals for community pharmacy in 2016/17 and beyond, including the proposal for a Pharmacy Access Scheme. In parallel, we also want to hear views on our proposals from across the sector and from patient groups. We published our open letter to the PSNC on 17 December 2015 and on 27 January 2016 we published a set of slides setting out the proposals with a foreword by the Chief Pharmaceutical Officer.
We announced on 16 March 2016 that the consultation period was to be extended to allow more time to develop the proposed changes with the PSNC and others. It will now close on 24 May 2016.
Once we have carefully considered the outcomes from the consultation, we are looking to communicate final decisions as soon as possible, so that pharmacy contractors are fully informed some months before the funding reduction starts from October 2016.
The role of the general practice pharmacist is distinct from the role of the pharmacist in a community setting. However, they are synergistic. Pharmacists working in general practice will, in the main, work with patients who have long term conditions to support them with their medicines and self-management of their condition by helping with the development and review of individual care plans. These patients will not generally be those with minor illnesses which can be treated by seeing a pharmacist in a community setting and for whom community pharmacy will remain the first, and most appropriate, option.
To ask the Secretary of State for Health, what meetings (a) Ministers and (b) officials of his Department have had with representatives of the Pharmaceutical Services Negotiating Committee since May 2015.
To ask the Secretary of State for Health, what meetings (a) Ministers and (b) officials of his Department have had with representatives of the Pharmaceutical Services Negotiating Committee since May 2015.
Ministers and officials in the Department meet with representatives of the Pharmaceutical Services Negotiating Committee (PSNC) on a regular basis to discuss issues such as drug reimbursement, remuneration and service developments and amendments to legislation. We have been in discussions with the PSNC since December 2015 regarding the Government’s proposals for community pharmacy in 2016/17 and beyond.
To ask the Secretary of State for Health what recent discussions his Department has had with the Pharmaceutical Services Negotiating Committee on future funding arrangements for community pharmacy services.
[131450]
To ask the Secretary of State for Health what recent discussions his Department has had with the Pharmaceutical Services Negotiating Committee on future funding arrangements for community pharmacy services.
[131450]
The Department of Health and the Pharmaceutical Services Negotiating Committee are in active negotiations following publication of the “Cost of Service Inquiry for Community Pharmacy”. In determining the quantum and arrangements for future funding, there are a number of further considerations to take into account, including:
any adjustments, for example, in respect of the extent to which the national health services should pay for different categories of cost, as well as uprating the cost of service inquiry findings to the current year;
reviewing the medicine margin arrangements, taking into account the recommendations of the National Audit Office, such as extending the medicine margin survey beyond independent pharmacies
to other pharmacy types, with a consistent approach on cost of service, and making more timely adjustments to medicine margin to reduce regulatory lag; and
reviewing the distribution of community pharmacy contractual framework (CPCF) funding to incentivise and support high quality and efficient services.
Pending completion of those negotiations, an interim position, which maintains CPCF funding at £2,486 million per annum, is in place.
(3) when he last discussed shortages of medicines at local pharmacies with the Pharmaceutical Services Negotiating Committee;
[109056]
Huw Irranca-Davies:
(3) when he last discussed shortages of medicines at local pharmacies with the Pharmaceutical Services Negotiating Committee;
[109056]
Huw Irranca-Davies:
Ministers regularly meet with interested parties and discuss medicines supply issues when they are raised. Officials regularly meet with interested parties to explicitly discuss medicines supply issues.
A vision for pharmacy in the new NHS. 26 p.
A vision for pharmacy in the new NHS. 26 p.
To ask the Secretary of State for Health, when he expects to agree pharmacists' remuneration terms for 2001-02.
To ask the Secretary of State for Health, when he expects to agree pharmacists' remuneration terms for 2001-02.